BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16098426)

  • 21. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
    Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
    Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.
    Berger JS; Sanborn TA; Sherman W; Brown DL
    Am Heart J; 2006 May; 151(5):1026-31. PubMed ID: 16644329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.
    Blackledge HM; Squire IB
    Heart; 2009 Feb; 95(4):304-11. PubMed ID: 19001000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years.
    Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2006 Jul; 119(14):1151-6. PubMed ID: 16863605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention.
    Upadhya B; Sane DC; Applegate RJ; Kutcher MA; Gandhi SK; Deliargyris EN
    J Invasive Cardiol; 2005 May; 17(5):243-7. PubMed ID: 15879602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous coronary intervention outcomes in a low-volume center: survival, stent thrombosis, and repeat revascularization.
    Kenney KM; Marzo MC; Ondrasik NR; Wisenbaugh T
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):671-7. PubMed ID: 20031907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK).
    Zahn R; Gottwik M; Hochadel M; Senges J; Zeymer U; Vogt A; Meinertz T; Dietz R; Hauptmann KE; Grube E; Kerber S; Sechtem U;
    Heart; 2008 Mar; 94(3):329-35. PubMed ID: 17664190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients.
    Yasuda K; Kasuga H; Aoyama T; Takahashi H; Toriyama T; Kawade Y; Iwashima S; Yamada S; Kawahara H; Maruyama S; Yuzawa Y; Ishii H; Murohara T; Matsuo S
    J Am Soc Nephrol; 2006 Aug; 17(8):2322-32. PubMed ID: 16837633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
    Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.
    Yan BP; Gurvitch R; Duffy SJ; Clark DJ; Sebastian M; New G; Warren R; Lefkovits J; Lew R; Brennan AL; Reid C; Andrianopoulos N; Ajani AE
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):928-36. PubMed ID: 18044763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention.
    Naidu SS; Vlachos H; Faxon D; Jacobs AK; Selzer F; Detre K; Wilensky RL
    Am J Cardiol; 2005 Mar; 95(5):575-80. PubMed ID: 15721094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.